BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32529519)

  • 1. Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.
    Liao J; Ding F; Luo W; Nie X; He Y; Li G
    Dig Dis Sci; 2021 May; 66(5):1533-1539. PubMed ID: 32529519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test.
    Li X; Zhang F; Chen H; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
    Endocr J; 2017 Jan; 64(1):49-57. PubMed ID: 27725372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
    Nauck MA; Meier JJ
    Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
    Nauck M; Stöckmann F; Creutzfeldt W
    Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
    Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
    Ueda K; Kawabe K; Lee L; Tachibana Y; Fujimori N; Igarashi H; Oda Y; Jensen RT; Takayanagi R; Ito T
    Pancreas; 2017 Apr; 46(4):476-481. PubMed ID: 28230660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
    van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
    Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity.
    Iizuka K; Fujisawa T; Takeda J
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide during the prolonged fast in insulinoma.
    Service FJ; O'Brien PC; McMahon MM; Kao PC
    J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma and pregnancy.
    Müssig K; Wehrmann M; Horger M
    Fertil Steril; 2009 Feb; 91(2):656. PubMed ID: 19111295
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose-responsive insulinoma in a patient with postprandial hypoglycemia in the morning.
    Iida K; Ohara T; Hino Y; Nobuhara M; Ishida J; Chihara K
    Intern Med; 2010; 49(19):2123-7. PubMed ID: 20930440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
    Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: a glucose responsive insulinoma--implication for the diagnosis of insulin secreting tumors.
    Sjoberg RJ; Kidd GS
    Am J Med Sci; 1992 Sep; 304(3):164-7. PubMed ID: 1476155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forty-eight-hour fast: the diagnostic test for insulinoma.
    Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
    McMahon MM; O'Brien PC; Service FJ
    Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin surrogates in insulinoma.
    O'Brien T; O'Brien PC; Service FJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
    Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
    Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
    Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma.
    Service FJ; O'Brien PC; Kao PC; Young WF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):204-10. PubMed ID: 1727822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of insulin secretion patterns in insulinoma.
    Saddig C; Goretzki PE; Starke AA
    World J Surg; 2008 May; 32(5):918-29. PubMed ID: 18259806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.